The prevalence of PD-L1 expression in patients with advanced oesophageal cancer: the EXCEED observational study
These real-world data provide a robust estimate of the prevalence of high PD-L1 expression in patients with advanced OC and identify clinicopathological and treatment features related to PD-L1 expression that can inform treatment selection.
Authors
- Jianming Ying (ORCID: https://orcid.org/0000-0003-2692-4052)
- Du He (ORCID: https://orcid.org/0000-0002-6358-3130)
- Yan Jin (ORCID: https://orcid.org/0009-0009-0047-0161)
- Dong Kuang (ORCID: https://orcid.org/0000-0002-8455-3379)
- Jielin Li (ORCID: https://orcid.org/0000-0003-3677-4561)
- Pei Duan
- Wenmin Tang
- Liyan Xue (ORCID: https://orcid.org/0000-0001-5185-0126)
- Lili Jiang
- Daoyuan Wu
- Yan Wang (ORCID: https://orcid.org/0000-0002-8302-3704)
- Jiaqi Wang (ORCID: https://orcid.org/0000-0002-8616-3200)
- Yuan Li (ORCID: https://orcid.org/0009-0000-0126-1331)
- Jing Qian (ORCID: https://orcid.org/0000-0003-4425-6123)
- Jing‐Ping Yun
- Shi‐Xun Lu
Institutions
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Sichuan University (CN)
- National Cancer Center (US)
- West China Hospital of Sichuan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Henan Cancer Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Journal of Clinical Pathology
- Published
- 2025-01-28
- DOI
- https://doi.org/10.1136/jcp-2024-209721
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00